Login to Your Account

Sanofi Building Vaccine Pipeline with $549M Buyout of Acambis

By Jennifer Boggs

Monday, July 28, 2008
London-based Acambis plc is being acquired by Sanofi Pasteur Holding, the vaccines division of Paris-based Sanofi-Aventis Group, in a deal valued at about £276 million (US$549 million), as the overseas buyout trend continues. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription